HYPE Price Drop Triggers Major Whale Loss

Finance Share Share this article

Copy linkX (Twitter)LinkedInFacebookEmail

PNC Bank Rolls Out Spot Bitcoin Ac

The post Solana’s (SOL) Recent Rally May Impress, But Investors Targeting Life-Changing ROI Are Looking Elsewhere appeared on BitcoinEthereumNews.com. Solana’s (SOL) latest rally has attracted investors from all over, but the bigger story for vision-minded investors is where the next surges of life-altering returns are heading.  As Solana continues to see high levels of ecosystem usage and network utilization, the stage is slowly being set for Mutuum Finance (MUTM).  MUTM is priced at $0.035 in its fast-growing presale. Price appreciation of 14.3% is what the investors are going to anticipate in the next phase. Over $15.85 million has been raised as the presale keeps gaining momentum. Unlike the majority of the tokens surfing short-term waves of hype, Mutuum Finance is becoming a utility-focused choice with more value potential and therefore an increasingly better option for investors looking for more than price action alone. Solana Maintains Gains Near $234 As Speculation Persists Solana (SOL) is trading at $234.08 currently, holding its 24hr range around $234.42 to $248.19 as it illustrates the recent trend. The token has recorded strong seven-day gains of nearly 13%, far exceeding most of its peers, as it is supported by rising volume and institutional buying. Resistance is at $250-$260, and support appears to be at $220-$230, and thus these are significant levels for potential breakout or pullback.  However, new DeFi crypto Mutuum Finance, is being considered by market watchers to have more upside potential, being still in presale.  Mutuum Finance Phase 6 Presale Mutuum Finance is currently in Presale Stage 6 and offering tokens for $0.035. Presale has been going on very fast, and investors have raised over $15.85 million. The project also looks forward to a USD-pegged stablecoin on the Ethereum blockchain for convenient payments and as a keeper of long-term value. Mutuum Finance is a dual-lending, multi-purpose DeFi platform that benefits borrowers and lenders alike. It provides the network to retail as well as…

TLDR JPMorgan initiated coverage on Vor Biopharma (NASDAQ:VOR) with an Overweight rating and $43 price target, representing over 400% upside from current levels The investment bank views telitacicept, a dual APRIL/BAFF inhibitor licensed from RemeGen, as “highly de-risked” across multiple autoimmune disease indications Vor Biopharma owns rights to telitacicept outside of China, targeting Myasthenia Gravis [...] The post Vor Biopharma (VOR) Stock Explodes 40% as JPMorgan Sees Massive Upside Ahead appeared first on Blockonomi.